Effect of changing s.c. epoetin alfa administration from thrice weekly to once weekly in hemodialysis patients

被引：1
|
作者：
To, LL
Stoner, CP
机构：
[1] VA San Diego Healthcare Syst, Dept Pharm 119, La Jolla, CA 92161 USA
[2] Univ Pacific, Sch Pharm, Stockton, CA 95211 USA
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2003年 / 60卷 / 09期
关键词：
D O I：
10.1093/ajhp/60.9.931
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：931 / 934
页数：4
相关论文
共 50 条
  • [41] Changing the frequency of administration of darbepoetin alfa (from weekly to fortnightly) maintains the haemoglobin levels in patients undergoing peritoneal dialysis
    Bajo, M. A.
    Perez Fontan, M.
    Remon, C.
    Sanchez-Tomero, J. A.
    Llados, F.
    Selgas, R.
    NEFROLOGIA, 2009, 29 (02): : 136 - 142
  • [42] Efficacy of Once-weekly Intravenous Administration of Epoetin-β as a Maintenance Treatment for Anemia in Japanese Hemodialysis Patients: A Multicenter, Open-label Clinical Study
    Shigematsu, Takashi
    Takami, Hiroya
    Shimizu, Tatsuo
    Shimoyama, Hiromi
    Kim, Songsu
    Hirose, Satoru
    Sakai, Takehiko
    Kono, Takashi
    Mochizuki, Takahiro
    Nishio, Kyosuke
    Degawa, Hisakazu
    Motomiya, Yoshihiro
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (06) : 469 - 474
  • [43] Once-weekly dosing of epoetin alfa increases hemoglobin (Hb) and improves quality of life (QOL) in patients with hematologic malignancies.
    Gabrilove, JL
    Einhorn, LH
    Cleeland, CS
    Livingston, RB
    Winer, E
    BLOOD, 1999, 94 (10) : 400A - 400A
  • [44] Rapid hemoglobin response in anemic cancer patients undergoing chemotherapy or chemoradiation therapy receiving once-weekly epoetin alfa treatment
    Shasha, D
    George, M
    BLOOD, 2002, 100 (11) : 17B - 17B
  • [45] Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients
    Grossman, HA
    Goon, B
    Bowers, P
    Leitz, G
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (04) : 368 - 378
  • [46] Epoetin alfa 40000 U once weekly and intravenous iron supply in solid tumor patients: Early increase of hemoglobin level during chemotherapy
    Lalle, M
    Pistillucci, G
    Antimi, M
    D'Aprile, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2005, 24 (02) : 196 - 201
  • [47] Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study
    Donck, Jan
    Gonzalez-Tabares, Lourdes
    Chanliau, Jacques
    Martin, Heike
    Stamatelou, Kyriaki
    Manamley, Nick
    Farouk, Mourad
    Addison, Janet
    ADVANCES IN THERAPY, 2014, 31 (11) : 1155 - 1168
  • [48] Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study
    Jan Donck
    Lourdes Gonzalez-Tabares
    Jacques Chanliau
    Heike Martin
    Kyriaki Stamatelou
    Nick Manamley
    Mourad Farouk
    Janet Addison
    Advances in Therapy, 2014, 31 : 1155 - 1168
  • [49] Once weekly epoetin alfa increase hemoglobin and decreases RBV discontinuation among HCV patients who develop anemia on RBV/INF therapy.
    Wasserman, R
    Brau, N
    Hassanein, TI
    Bini, E
    Sulkowski, M
    Dieterich, D
    HEPATOLOGY, 2000, 32 (04) : 368A - 368A
  • [50] Efficiency of once-weekly subcutaneous administration of recombinant human erythropoietin versus th ree times a week administration in hemodialysis patients
    Lago, M
    PerezGarcia, R
    deVinuesa, MSG
    Anaya, F
    Valderrabano, F
    NEPHRON, 1996, 72 (04) : 723 - 724
12345